Gainers
- 1Life Healthcare ONEM stock increased by 8.7% to $17.9 during Tuesday's after-market session. Trading volume for this security closed at 2.5 million, accounting for 100.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.6 billion.
- Tivic Health Systems TIVC shares rose 7.84% to $0.21. The company's market cap stands at $6.2 million.
- Brookdale Senior Living BKD stock increased by 6.95% to $3.23. The company's market cap stands at $603.3 million. As per the news, the Q4 earnings report came out today.
- Prenetics Global PRE shares increased by 5.0% to $1.05. The company's market cap stands at $124.7 million.
- AquaBounty Technologies AQB stock moved upwards by 4.99% to $0.85. The market value of their outstanding shares is at $60.4 million.
- Harpoon Therapeutics HARP shares rose 4.99% to $0.87. The market value of their outstanding shares is at $29.0 million.
Losers
- Procaps Gr PROC stock declined by 13.4% to $3.94 during Tuesday's after-market session. The company's market cap stands at $444.5 million.
- LianBio LIAN stock fell 8.86% to $1.85. The company's market cap stands at $200.9 million.
- GlycoMimetics GLYC stock decreased by 7.3% to $1.78. This security traded at a volume of 81.8K shares come close, making up 5.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $93.3 million.
- Minerva Surgical UTRS shares decreased by 6.86% to $0.4. The company's market cap stands at $71.0 million.
- Staar Surgical STAA stock decreased by 6.86% to $62.9. The company's market cap stands at $3.0 billion. As per the press release, Q4 earnings came out today.
- eFFECTOR Therapeutics EFTR stock decreased by 6.57% to $0.47. Today's trading volume for this security ended up closing at 250.3K shares, which is 81.2 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $19.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in